0001237899-20-000006.txt : 20200128 0001237899-20-000006.hdr.sgml : 20200128 20200128170623 ACCESSION NUMBER: 0001237899-20-000006 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200127 FILED AS OF DATE: 20200128 DATE AS OF CHANGE: 20200128 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MURPHY ANDREW J CENTRAL INDEX KEY: 0001796226 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 20555416 MAIL ADDRESS: STREET 1: REGENERON PHARMACEUTICALS, INC. STREET 2: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2020-01-27 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001796226 MURPHY ANDREW J 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 EVP Research Common Stock 2020-01-27 4 S 0 200 336.78 D 57751 D Common Stock 2020-01-27 4 S 0 270 337.46 D 57481 D Common Stock 2020-01-27 4 S 0 712 338.54 D 56769 D Common Stock 2020-01-27 4 S 0 567 339.37 D 56202 D Common Stock 2020-01-27 4 S 0 1355 340.56 D 54847 D Common Stock 2020-01-27 4 S 0 3283 341.58 D 51564 D Common Stock 2020-01-27 4 S 0 1399 342.44 D 50165 D Common Stock 2020-01-27 4 S 0 214 343.02 D 49951 D Common Stock 4212 I By 401(k) Plan Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 200 shares of Company stock on January 27, 2020 at prices ranging from $336.55 to $336.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 27, 2020 at each separate price. Represents volume-weighted average price of sales of 270 shares of Company stock on January 27, 2020 at prices ranging from $337.01 to $337.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 27, 2020 at each separate price. Represents volume-weighted average price of sales of 712 shares of Company stock on January 27, 2020 at prices ranging from $338.07 to $338.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 27, 2020 at each separate price. Represents volume-weighted average price of sales of 567 shares of Company stock on January 27, 2020 at prices ranging from $339.01 to $339.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 27, 2020 at each separate price. Represents volume-weighted average price of sales of 1,355 shares of Company stock on January 27, 2020 at prices ranging from $340.05 to $340.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 27, 2020 at each separate price. Represents volume-weighted average price of sales of 3,283 shares of Company stock on January 27, 2020 at prices ranging from $341.03 to $341.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 27, 2020 at each separate price. Represents volume-weighted average price of sales of 1,399 shares of Company stock on January 27, 2020 at prices ranging from $342.00 to $342.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 27, 2020 at each separate price. Represents volume-weighted average price of sales of 214 shares of Company stock on January 27, 2020 at prices ranging from $343.00 to $343.02. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 27, 2020 at each separate price. /s/**Andrew Murphy 2020-01-28